During the past decade, Georg-Haas-Dialysezentrum der PHV conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Georg-Haas-Dialysezentrum der PHV" are "Chronic Renal Anemia" (1 trials), "End Stage Renal Disease" (1 trials) and "Renal Failure" (1 trials). Many other conditions were trialed in "Georg-Haas-Dialysezentrum der PHV" in a lesser frequency.

Most popular intervention types in "Georg-Haas-Dialysezentrum der PHV" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Darbepoetin Alfa" (1 trials), "Dialyzer" (1 trials), "Epoetin Alfa" (1 trials), "Epoetin Beta" (1 trials) and "methoxy polyethylene glycol-epoetin beta" (1 trials). Other intervention names were less common.

The vast majority of trials in "Georg-Haas-Dialysezentrum der PHV" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Georg-Haas-Dialysezentrum der PHV". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Georg-Haas-Dialysezentrum der PHV, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Georg-Haas-Dialysezentrum der PHV, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".